Evidence map›Paper›PMID 39318913›Full record

ArticleCureus2024

Exploring the Potential of DALL-E 2 in Pediatric Dermatology: A Critical Analysis.

Subin Lim, Sarah Kooper-Johnson, Courtney A Chau, Sarah Robinson, Gabriela Cobos

Abstract read
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Subin LimDermatology, Eastern Virginia Medical School, Norfolk, USA.
Sarah Kooper-JohnsonDermatology, Tufts Medical Center, Boston, USA.
Courtney A ChauDermatology, Icahn School of Medicine at Mount Sinai, New York City, USA.
Sarah RobinsonDermatology, Tufts Medical Center, Boston, USA.
Gabriela CobosDermatology, Tufts Medical Center, Boston, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionArtificial intelligence (AI) is becoming increasingly explored for its potential applications in dermatology. Among various AI models, DALL-E 2 (San Francisco, CA: OpenAI), which generates de novoimages from textual inputs, has garnered significant attention for its remarkable photorealism. In our study, we aimed to analyze the performance of DALL-E 2 in the context of dermatology.

methodsThe following 12 pediatric dermatological conditions common to ages <15 years were selected as tests: acne, atopic dermatitis, contact dermatitis, vitiligo, congenital melanocytic nevus, warts, molluscum contagiosum, seborrheic dermatitis, alopecia areata, infantile hemangioma, impetigo, and dermatophytosis, specifically tinea corporis. Representative morphological descriptions of each diagnosis, along with their corresponding names, were inputted into DALL-E 2 as textual prompts and subsequently compared. The accuracy of the generated images and their alignment with the intended descriptions were assessed.

resultsAmong the total of 24 images reported, 18 were photorealistic and six were cartoons. More cartoons were generated when providing the model with morphological descriptions as textual inputs compared to when diagnoses were inputted. While not entirely accurate, acne stood out as the only diagnosis that was the most consistent and closest to the actual diagnosis. Both images of acne portrayed erythematous papules scattered across the face. However, DALL-E 2 resulted in poor performance for the remaining eleven diagnoses. They did not accurately represent the intended diagnoses nor align with their counterpart image. Moreover, most of the generated images featured lighter skin tones.

conclusionIn assessing DALL-E 2's applications in dermatology, our study highlights the need for more domain-specific and demographically inclusive training data in its algorithms to improve performance.

Indexed as

artificial intelligencedermatologymedical educationpediatric dermatologytechnological innovation

Identifiers

PMID39318913
PMCPMC11421884

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.